HSBC Holdings
WVE icon

HSBC Holdings’s Wave Life Sciences WVE Stock Holding History

HSBC Holdings’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,990
Closed -$291K – 3266
2025
Q4 		$291K Buy
16,990
+5,823
+52% +$59.2K ﹤0.01% 2541
2025
Q3 		$81.7K Buy
+11,167
New +$90.3K ﹤0.01% 2613
2025
Q2 		– Sell
-11,158
Closed -$89.5K – 3266
2025
Q1 		$89.5K Buy
11,158
+437
+4% +$4.78K ﹤0.01% 2828
2024
Q4 		$132K Sell
10,721
-3,565
-25% -$47.6K ﹤0.01% 2829
2024
Q3 		$119K Sell
14,286
-7,158
-33% -$42.8K ﹤0.01% 2766
2024
Q2 		$104K Buy
+21,444
New +$122K ﹤0.01% 2720

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

HSBC Holdings's WVE Position: Q1 2026 in Review

HSBC Holdings sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 16,990 shares — an estimated $291K sold.

HSBC Holdings first reported a position in WVE in Q2 2024 and held it in 6 quarters. The position peaked at $291K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • HSBC Holdings reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • HSBC Holdings sold 16,990 Wave Life Sciences shares in Q1 2026, an estimated $291K.
  • HSBC Holdings first reported a position in Wave Life Sciences in Q2 2024 and held it in 6 quarters.
  • HSBC Holdings's Wave Life Sciences position peaked at $291K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.